None
Quote | Alterity Therapeutics Limited (NYSE:ATHE)
Last: | $ |
---|---|
Change Percent: | -5.61% |
Open: | $0.77 |
Close: | $0.7113 |
High: | $0.7763 |
Low: | $0.7011 |
Volume: | 35,028 |
Last Trade Date Time: | 02/12/2020 04:41:14 pm |
News | Alterity Therapeutics Limited (NYSE:ATHE)
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today an...
- New bioMUSE Data Informs ATH434-202 Study Endpoints - - Webcast to Include Key Opinion Leader, Daniel Claassen, M.D., M.S., Vanderbilt University - MELBOURNE, Australia and SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ( ...
Message Board Posts | Alterity Therapeutics Limited (NYSE:ATHE)
Subject | By | Source | When |
---|---|---|---|
she will soon enough my friend! athe volume | NYCJR | investorshub | 07/18/2022 9:56:04 PM |
soo oversold its not even funny, also float | NYCJR | investorshub | 07/18/2022 4:14:36 PM |
more news should be coming in the next | NYCJR | investorshub | 07/18/2022 4:14:03 PM |
remember folks, this ran hard around this time | NYCJR | investorshub | 07/18/2022 4:13:25 PM |
building myself a nice little position here folks! | NYCJR | investorshub | 07/16/2022 1:02:13 AM |
News, Short Squeeze, Breakout and More Instantly...
Alterity Therapeutics Limited Company Name:
ATHE Stock Symbol:
NYSE Market:
Alterity Therapeutics Limited Website:
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today an...
- New bioMUSE Data Informs ATH434-202 Study Endpoints - - Webcast to Include Key Opinion Leader, Daniel Claassen, M.D., M.S., Vanderbilt University - MELBOURNE, Australia and SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ( ...
- ATH434-201 Trial on Track to Complete in November 2024 – - Top-Line Data Expected in January 2025 - MELBOURNE, Australia and SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Companyȁ...